Literature DB >> 15953465

Electrophysiological changes in lipaemia retinalis.

Chao-Kung Lu1, Shih-Jen Chen, Dau-Ming Niu, Chia-Chen Tsai, Fenq-Lih Lee, Wen-Ming Hsu.   

Abstract

PURPOSE: To report the electrophysiologic findings in a patient with lipaemia retinalis.
DESIGN: Observational case report.
METHODS: An 11-year-old girl with diabetes had hyperlipidemia and presented for ophthalmologic consultation. Fundus examinations revealed milky discoloration of retinal vessels in both eyes. Laboratory testing disclosed hyperglycemia and markedly elevated level of triglycerides and cholesterol. Although the visual acuity was not affected, the electroretinograms showed decrease amplitudes of a- and b-wave in both cone and rod responses.
RESULTS: After correction of blood sugar and lipids with insulin and diet control, the lipaemia retinalis resolved, and the impaired ERG response reversed within 1 week.
CONCLUSIONS: Lipaemia retinalis usually resolves rapidly without visual impairment after correction of hyperlipidemia. The reversible deficits of electroretinogram response in lipaemia retinalis are reported for the first time. High level of triglycerides or cholesterol or both may impair retinal function. The mechanism of an impaired electroretinogram remained speculative.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953465     DOI: 10.1016/j.ajo.2004.12.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Reduced retinal blood flow-velocity in severe hyperlipidemia measured by the retinal function imager.

Authors:  Yael Birger; Oren Blumenfeld; Elisha Bartov; Zvia Burgansky-Eliash
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-06-04       Impact factor: 3.117

2.  Rapid resolution of infantile lipemia retinalis following exchange transfusion.

Authors:  Cara E Capitena; Holly J Wagoner; Christopher M Ruzas; Tellen D Bennett; Peter R Baker; Jennifer L Jung; James D Weisfeld-Adams
Journal:  J Inherit Metab Dis       Date:  2016-08-12       Impact factor: 4.982

3.  Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis.

Authors:  Waleed K Alsarhani; Fadwa F Al Adel; Abdullah Alamri; Rahaf M Al Malawi; Abdulrahman F AlBloushi
Journal:  BMC Ophthalmol       Date:  2022-07-06       Impact factor: 2.086

4.  Lipemia retinalis in 1-month-old infant.

Authors:  Neha C Jain; Jyothi Vanteri; Parag K Shah; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2017 Jan-Apr

5.  Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.

Authors:  Nehal M El-Koofy; Yasmeen A Abdo; Dina El-Fayoumi; Amanne F Esmael; Mohamed A Elmonem; Zahraa Ezzeldin
Journal:  Lipids Health Dis       Date:  2021-04-20       Impact factor: 3.876

6.  Retinal lipemia as expression of hyperchylomicronemia syndrome.

Authors:  Jon Ortiz de Salido-Menchaca; Manuel Antonio Tazón-Varela; David de la Hera-Vegas; Rosa Herreras-Martínez; Sergio Andrés Álvarez-Agudelo; Nuria Arencibia-Hernández
Journal:  Colomb Med (Cali)       Date:  2021-03-30

7.  Lipemia retinalis with different therapeutic responses: A report of two cases.

Authors:  Chun-Chieh Lai; Chun-Hsiang Chang
Journal:  Taiwan J Ophthalmol       Date:  2021-01-20

8.  Lipemia Retinalis Diagnosed Incidentally After Laser Photocoagulation Treatment for Retinopathy of Prematurity

Authors:  Taylan Öztürk; Ezgi Karataş Yiğitaslan; Pelin Teke Kısa; Hüseyin Onay; Ali Osman Saatci
Journal:  Turk J Ophthalmol       Date:  2021-10-26

9.  Lipemia Retinalis, Macular Edema, and Vision Loss in a Diabetic Patient with a History of Type IV Hypertriglyceridemia and Pancreatitis.

Authors:  John W Hinkle; Nidhi Relhan; Harry W Flynn
Journal:  Case Rep Ophthalmol       Date:  2018-10-02

10.  Lipemia Retinalis in a Patient with Familial Hypertriglyceridemia.

Authors:  Patrick Wang; Eric K Chin; David R P Almeida
Journal:  J Clin Imaging Sci       Date:  2020-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.